Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Colleen Redlinger"'
Autor:
William J. Chapin, Jacob E. Till, Wei-Ting Hwang, Jennifer R. Eads, Thomas B. Karasic, Peter J. O'Dwyer, Charles J. Schneider, Ursina R. Teitelbaum, Janae Romeo, Taylor A. Black, Theresa E. Christensen, Colleen Redlinger Tabery, Amanda Anderson, Megan Slade, Michael LaRiviere, Stephanie S. Yee, Kim A. Reiss, Mark H. O'Hara, Erica L. Carpenter
Publikováno v:
JCO precision oncology. 6
PURPOSE Pancreatic ductal adenocarcinoma (PDAC) is associated with a poor prognosis. Multianalyte signatures, including liquid biopsy and traditional clinical variables, have shown promise for improving prognostication in other solid tumors but have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b5c3a9a69c1348cb58b0dfe0498373
https://pubmed.ncbi.nlm.nih.gov/35939771
https://pubmed.ncbi.nlm.nih.gov/35939771
Autor:
Angela M. DeMichele, Peter J. O'Dwyer, Kevin R. Fox, Susan M. Domchek, Angela R. Bradbury, Maryann Gallagher, Colleen Redlinger, Jessica Burrell, Mark Rosen, Priti Lal, Michael Feldman, Andrea Troxel, Nicholas P. McAndrew, Amy S. Clark
Supplementary Figure 1: Trial Enrollment Schema Supplementary Figure 2: Kaplan Meier Curve Among Patients Receiving Palbociclib and Paclitaxel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ff68390953a0e1dd3a4d10a26dfe9b
https://doi.org/10.1158/1078-0432.22471707.v1
https://doi.org/10.1158/1078-0432.22471707.v1
Autor:
Angela M. DeMichele, Peter J. O'Dwyer, Kevin R. Fox, Susan M. Domchek, Angela R. Bradbury, Maryann Gallagher, Colleen Redlinger, Jessica Burrell, Mark Rosen, Priti Lal, Michael Feldman, Andrea Troxel, Nicholas P. McAndrew, Amy S. Clark
KM Curves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22da2a0269c9cb62f5e3a013987edfe6
https://doi.org/10.1158/1078-0432.22471710
https://doi.org/10.1158/1078-0432.22471710
Autor:
Angela M. DeMichele, Peter J. O'Dwyer, Kevin R. Fox, Susan M. Domchek, Angela R. Bradbury, Maryann Gallagher, Colleen Redlinger, Jessica Burrell, Mark Rosen, Priti Lal, Michael Feldman, Andrea Troxel, Nicholas P. McAndrew, Amy S. Clark
Purpose:The CDK 4/6 inhibitor palbociclib rapidly and reversibly inhibits the cell cycle. The goal of this study was to exploit the cell cycle through intermittent, alternating dosing with palbociclib/paclitaxel to enhance efficacy. We determined the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d5c8fe5b94ee5a0dd12850f50afa22
https://doi.org/10.1158/1078-0432.c.6527973.v1
https://doi.org/10.1158/1078-0432.c.6527973.v1
Autor:
Angela M. DeMichele, Peter J. O'Dwyer, Kevin R. Fox, Susan M. Domchek, Angela R. Bradbury, Maryann Gallagher, Colleen Redlinger, Jessica Burrell, Mark Rosen, Priti Lal, Michael Feldman, Andrea Troxel, Nicholas P. McAndrew, Amy S. Clark
Dose Cohort Scema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1073572a62e0113190fecd86383fd91e
https://doi.org/10.1158/1078-0432.22471713
https://doi.org/10.1158/1078-0432.22471713
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dan T. Vogl, Colleen Redlinger Tabery, Robert H. Vonderheide, Maria C. Hendricks, Emma A. Meagher, Erica Dahlmeier, Meghan L. Blair, Vicki Sallee, Roger B. Cohen
Publikováno v:
CancerReferences. 127(16)
With rapid modifications in cancer clinical trial operations necessitated by the global pandemic over the last year, there is now an unprecedented opportunity to reform clinical research permanently and solidify innovative practices that have clearly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0efe8b71d86dfc76e06b961a1881053
https://pubmed.ncbi.nlm.nih.gov/33849079
https://pubmed.ncbi.nlm.nih.gov/33849079
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Colleen Redlinger, Craig Newcomb, Elizabeth M. Jaffee, Lisa M. Coussens, Katelyn T. Byrne, Martin A. Cheever, Courtney Betts, Daniel A. Laheru, E. Gabriela Chiorean, Ana P. Ferreira, David L. Bajor, Cécile Alanio, Judith C Kaiser, Sara A. Väyrynen, Takuya Ohtani, Byung Park, Martin Stern, Rosemarie Mick, Brian M. Wolpin, Andressa Dias Costa, Shannon M. Liudahl, Jonathan A. Nowak, Andreanne M. Lacroix, Mark H. O'Hara, Austin P. Huffman, E. John Wherry, Shamilene Sivagnanam, Robert H. Vonderheide, Emma E. Furth
Publikováno v:
Cancer Research. 81:CT005-CT005
Deploying CD40 activation to stimulate T cell responses upstream of immune checkpoint molecules is a novel clinical opportunity for cancer immunotherapy. Despite numerous active clinical trials with agonistic CD40 monoclonal antibodies (mAb), biologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97db3f542b5c1a2a30c463c1f77cd457
https://doi.org/10.1158/1538-7445.am2021-ct005
https://doi.org/10.1158/1538-7445.am2021-ct005
Autor:
Colleen Redlinger, Erkut Borazanci, Ravi K. Amaravadi, Daniel A. Laheru, Ursina R. Teitelbaum, Peter J. O'Dwyer, Ana De Jesus-Acosta, Thomas B. Karasic, Jeffrey A. Drebin, Daniel D. Von Hoff, Jessica A. Burrell, Mark H. O'Hara, Kim A. Reiss, Arturo Loaiza-Bonilla
Publikováno v:
JAMA Oncol
Importance Autophagy is a mechanism of treatment resistance to chemotherapy that has a role in the maintenance of pancreatic cancer. Hydroxychloroquine sulfate (HCQ) is an inhibitor of autophagy that inhibits the fusion of the autophagosome to the ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e2e89ccf68aca9f7b6f9be3fad46b6
https://pubmed.ncbi.nlm.nih.gov/31120501
https://pubmed.ncbi.nlm.nih.gov/31120501